Towards Healthcare
Single Cell Sequencing Market Grows at 15.05% CAGR till 2034

Single Cell Sequencing Market 2025 Update North America Leads, APAC Growing Fastest

According to market projections, the single cell sequencing sector is expected to grow from USD 1.63 billion in 2024 to USD 6.65 billion by 2034, reflecting a CAGR of 15.05%. Advancements in sequencing technologies and increased funding for personalized medicine are further driving its expansion.

Content

  • Insight Code: 5970
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The single cell sequencing market is projected to reach USD 6.65 billion by 2034, growing at a CAGR of 15.05% from 2024 to 2034.

North America is currently leading the single cell sequencing market due to its advanced healthcare infrastructure, strong presence of key market players, and significant investments in genomics research.

The single cell sequencing market includes 5 segments by technology, by workflow stage, by application, by end user, by region.

Key trends include the growth due to rising demand for precise cellular analysis in cancer immunology and genetic research.

Applications include cancer research, immunology, neuroscience, developmental biology, infectious diseases, and personalized medicine.

Challenges include high costs, complex data analysis, potential technical noise, and difficulty in isolating high-quality single cells.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions